Provided by Tiger Trade Technology Pte. Ltd.

Eli Lilly

918.05
-12.3000-1.32%
Post-market: 917.00-1.0500-0.11%17:23 EDT
Volume:3.44M
Turnover:3.15B
Market Cap:867.91B
PE:40.00
High:929.00
Open:925.00
Low:905.11
Close:930.35
52wk High:1,133.95
52wk Low:623.78
Shares:945.38M
Float Shares:945.00M
Volume Ratio:1.26
T/O Rate:0.36%
Dividend:6.00
Dividend Rate:0.65%
EPS(TTM):22.95
EPS(LYR):22.95
ROE:101.16%
ROA:19.42%
PB:32.71
PE(LYR):40.00

Loading ...

Eli Lilly : Leerink Partners Raises Target Price to $1,296.00 From $1,234.00

THOMSON REUTERS
·
Feb 05

BUZZ-Street View: Eli Lilly's momentum is building despite pricing pressure

Reuters
·
Feb 05

Divergent Performance for Weight-Loss Drug Leaders: Eli Lilly Surges Over 10% on Strong Earnings

Deep News
·
Feb 05

Eli Lilly price target raised to $1,300 from $1,200 at BMO Capital

TIPRANKS
·
Feb 05

BMO Capital Adjusts PT on Eli Lilly and Co. to $1,300 From $1,200, Maintains Outperform Rating

MT Newswires Live
·
Feb 05

Eli Lilly : Morgan Stanley Raises Target Price to $1313 From $1290

THOMSON REUTERS
·
Feb 05

Eli Lilly : Truist Securities Raises Target Price to $1,281.00 From $1,182.00

THOMSON REUTERS
·
Feb 05

AMD Plummets 17.31% on Weak Outlook, Leading February 5th's Top 20 US Stock Volume Leaders

Deep News
·
Feb 05

Health Care Up After Eli Lilly Earnings -- Health Care Roundup

Dow Jones
·
Feb 05

Nasdaq Dips Over 400 Points; Eli Lilly Shares Surge Following Upbeat Earnings

Benzinga_recent_news
·
Feb 05

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EST

Reuters
·
Feb 05

Top Midday Stories: Lilly Shares Soar After Strong Q4 Earnings, Guidance; Uber Q4 EPS Misses Target, CFO Stepping Down

MT Newswires Live
·
Feb 05

Eli Lilly Reclaims $1 Trillion Market Cap After ‘Blowout Earnings’

TIPRANKS
·
Feb 05

Stock Track | Eli Lilly Soars 10.12% Intraday on Strong Q4 Earnings Beat and Upbeat 2026 Guidance for Weight-Loss Drugs

Stock Track
·
Feb 04

Eli Lilly Surpasses Earnings Projections and Boosts Full-Year Forecast

Deep News
·
Feb 04

US STOCKS-Wall St mixed as strong earnings counter software jitters

Reuters
·
Feb 04

Eli Lilly Exec Says Co Expects Orforglipron to Launch in the US in Q2 2026 and in Most International Markets During 2027 -Conf Call

THOMSON REUTERS
·
Feb 04

Eli Lilly Exec Says Price Is Expected to Be a Drag on Growth in the Low to Mid Teens Range in 2026 -Conf Call

THOMSON REUTERS
·
Feb 04

Eli Lilly CEO Says Number of People Engaging With Lilly Direct Increased to Over One Million Patients in 2025 -Conf Call

THOMSON REUTERS
·
Feb 04

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Pyxis Oncology (PYXS)

TIPRANKS
·
Feb 04